The transcription factor SOX18 regulates the expression of matrix metalloproteinase 7 and guidance molecules in human endothelial cells

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Hoeth, Martina ^a,c   Niederleithner, Heide ^b   Hofer Warbinek, Renate ^a   Bilban, Martin ^a   Mayer, Herbert ^a,d   Resch, Ulrike ^a   Lemberger, Christof ^a   Wagner, Oswald ^a   Hofer, Erhard ^a   Petzelbauer, Peter ^b   De Martin, Rainer ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c BAXTER INNOVATIONS GMBH   (Austria)

^d Austrian Science Fund   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN B2; MATRILYSIN; SEMAPHORIN; SEMAPHORIN 3G; TRANSCRIPTION FACTOR SOX18; UNCLASSIFIED DRUG; SMALL INTERFERING RNA; SOX18 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; ANGIOGENESIS; CELL CULTURE; CELL MOTION; CELL STRAIN HEK293; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

MUS;

CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 7; MICROARRAY ANALYSIS; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, SMALL INTERFERING; SOXF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84856105898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030982     Document Type: Article

References (44)

1. Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, et al. (2003) Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 72 (6): 1470-1478.
2. Francois M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, et al. (2008) Sox18 induces development of the lymphatic vasculature in mice. Nature 456 (7222): 643-647.
3. Hosking BM, Wang SC, Chen SL, Penning S, Koopman P, et al. (2001) SOX18 directly interacts with MEF2C in endothelial cells. Biochem Biophys Res Commun 287 (2): 493-500.
4. James K, Hosking B, Gardner J, Muscat GE, Koopman P, (2003) Sox18 mutations in the ragged mouse alleles ragged-like and opossum. Genesis 36 (1): 1-6.
5. Pennisi D, Gardner J, Chambers D, Hosking B, Peters J, et al. (2000) Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat Genet 24 (4): 434-437.
6. Sandholzer J, Hoeth M, Piskacek M, Mayer H, de Martin R, (2007) A novel 9-amino-acid transactivation domain in the C-terminal part of Sox18. Biochem Biophys Res Commun 360 (2): 370-374.
7. Pennisi D, Bowles J, Nagy A, Muscat G, Koopman P, (2000) Mice null for sox18 are viable and display a mild coat defect. Mol Cell Biol 20 (24): 9331-9336.
8. Hosking B, Francois M, Wilhelm D, Orsenigo F, Caprini A, et al. (2009) Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice. Development 136 (14): 2385-2391.
9. Matsui T, Kanai-Azuma M, Hara K, Matoba S, Hiramatsu R, et al. (2006) Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice. J Cell Sci 119 (Pt 17): 3513-3526.
10. Sakamoto Y, Hara K, Kanai-Azuma M, Matsui T, Miura Y, et al. (2007) Redundant roles of Sox17 and Sox18 in early cardiovascular development of mouse embryos. Biochem Biophys Res Commun 360 (3): 539-544.
11. Lioubinski O, Muller M, Wegner M, Sander M, (2003) Expression of Sox transcription factors in the developing mouse pancreas. Dev Dyn 227 (3): 402-408.
12. Olsson JE, Kamachi Y, Penning S, Muscat GE, Kondoh H, et al. (2001) Sox18 expression in blood vessels and feather buds during chicken embryogenesis. Gene 271 (2): 151-158.
13. Stanojcic S, Stevanovic M, (2000) The human SOX18 gene: cDNA cloning and high resolution mapping. Biochim Biophys Acta 1492 (1): 237-241.
14. Zhang C, Basta T, Klymkowsky MW, (2005) SOX7 and SOX18 are essential for cardiogenesis in Xenopus. Dev Dyn 234 (4): 878-891.
15. Cermenati S, Moleri S, Cimbro S, Corti P, Del Giacco L, et al. (2008) Sox18 and Sox7 play redundant roles in vascular development. Blood 111 (5): 2657-2666.
16. Herpers R, van de Kamp E, Duckers HJ, Schulte-Merker S, (2008) Redundant Roles for Sox7 and Sox18 in Arteriovenous Specification in Zebrafish. Circ Res 102 (1): 12-15.
17. Saitoh T, Katoh M, (2002) Expression of human SOX18 in normal tissues and tumors. Int J Mol Med 10 (3): 339-344.
18. Darby IA, Bisucci T, Raghoenath S, Olsson J, Muscat GE, et al. (2001) Sox18 is transiently expressed during angiogenesis in granulation tissue of skin wounds with an identical expression pattern to Flk-1 mRNA. Lab Invest 81 (7): 937-943.
19. Garcia-Ramirez M, Martinez-Gonzalez J, Juan-Babot JO, Rodriguez C, Badimon L, (2005) Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth. Arterioscler Thromb Vasc Biol 25 (11): 2398-2403.
20. Young N, Hahn CN, Poh A, Dong C, Wilhelm D, et al. (2006) Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development. J Natl Cancer Inst 98 (15): 1060-1067.
21. Luo M, Guo XT, Yang W, Liu LQ, Li LW, et al. (2008) Inhibition of tumor angiogenesis by cell-permeable dominant negative SOX18 mutants. Med Hypotheses 70 (4): 880-882.
22. Srinivasan RS, Geng X, Yang Y, Wang Y, Mukatira S, et al. (2010) The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev 24 (7): 696-707.
23. Hosking BM, Wang SC, Downes M, Koopman P, Muscat GE, (2004) The VCAM-1 gene that encodes the vascular cell adhesion molecule is a target of the Sry-related high mobility group box gene, Sox18. J Biol Chem 279 (7): 5314-5322.
24. Im HJ, Smirnov D, Yuhi T, Raghavan S, Olsson JE, et al. (2001) Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by Sox18. Mol Pharmacol 59 (6): 1486-1496.
25. Fontijn RD, Volger OL, Fledderus JO, Reijerkerk A, de Vries HE, et al. (2008) SOX-18 controls endothelial-specific Claudin-5 gene expression and barrier function. Am J Physiol Heart Circ Physiol 294 (2): H891-900.
26. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, et al. (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161 (3): 653-660.
27. Samant GV, Schupp MO, Francois M, Moleri S, Kothinti RK, et al. (2011) Sox factors transcriptionally regulate ROBO4 gene expression in developing vasculature in zebrafish. J Biol Chem 286 (35): 30740-30747.
28. de Martin R, Strasswimmer J, Philipson L, (1993) A new luciferase promoter insertion vector for the analysis of weak transcriptional activities. Gene 124 (1): 137-138.
29. Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, et al. (1996) Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med 183 (3): 1013-1022.
30. McGrory WJ, Bautista DS, Graham FL, (1988) A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163 (2): 614-617.
31. Mayer H, Bilban M, Kurtev V, Gruber F, Wagner O, et al. (2004) Deciphering regulatory patterns of inflammatory gene expression from interleukin-1-stimulated human endothelial cells. Arterioscler Thromb Vasc Biol 24 (7): 1192-1198.
32. Nowak DE, Tian B, Brasier AR, (2005) Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. Biotechniques 39 (5): 715-725.
33. Ding K, Lopez-Burks M, Sanchez-Duran JA, Korc M, Lander AD, (2005) Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. J Cell Biol 171 (4): 729-738.
34. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, et al. (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277 (39): 36288-36295.
35. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y, (2006) Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231 (1): 20-27.
36. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y, (1997) Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 322 (Pt 3): 809-814.
37. Kure T, Chang JH, Kato T, Hernandez-Quintela E, Ye H, et al. (2003) Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest Ophthalmol Vis Sci 44 (1): 137-144.
38. Aerts S, Van Loo P, Thijs G, Mayer H, de Martin R, et al. (2005) TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis. Nucleic Acids Res 33: W393-396.
39. Holnthoner W, Kerenyi M, Groger M, Kratochvill F, Petzelbauer P, (2006) Regulation of matrilysin expression in endothelium by fibroblast growth factor-2. Biochem Biophys Res Commun 342 (3): 725-733.
40. Downes M, Francois M, Ferguson C, Parton RG, Koopman P, (2009) Vascular defects in a mouse model of hypotrichosis-lymphedema-telangiectasia syndrome indicate a role for SOX18 in blood vessel maturation. Hum Mol Genet 18 (15): 2839-2850.
41. Patterson BC, Sang QA, (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272 (46): 28823-28825.
42. Fuller T, Korff T, Kilian A, Dandekar G, Augustin HG, (2003) Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J Cell Sci 116 (Pt 12): 2461-2470.
43. Taniguchi M, Masuda T, Fukaya M, Kataoka H, Mishina M, et al. (2005) Identification and characterization of a novel member of murine semaphorin family. Genes Cells 10 (8): 785-792.
44. Neufeld G, Lange T, Varshavsky A, Kessler O, (2007) Semaphorin signaling in vascular and tumor biology. Adv Exp Med Biol 600: 118-131.